Luprohal 22.5mg Injection

Luprohal 22.5mg Injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. Luprohal 22.5mg Injection treats prostate cancer in men, hormone-responsive breast cancer,  and endometriosis (tissue that usually lines the interior of the uterus grows outside of it) and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used in treating premature puberty (central precocious puberty); due to certain hormonal releases, a child’s body begins to change into an adult at an early age.

Do not receive this injection if you are allergic to Leuprolide acetate or any other ingredients, including Goserelin and Triptorlin of the medicine. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. , Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.

Before starting the treatment, notify your doctor about your underlying medical conditions, such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or are at increased risk of thinning of bones (osteoporosis). This medicine is not recommended in pregnant and breastfeeding women and patients with abnormal vaginal bleeding. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Luprohal 22.5mg Injection. Report to your doctor if you are a man with urinary obstruction or had an operation to remove your testicles. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).